drugset / Trial / NCT00022282
AE-941 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Open-labelTreatment
Summary
RATIONALE: AE-941 may help to slow the growth of multiple myeloma. PURPOSE: Phase II trial to study the effectiveness of neovastat in treating patients who have relapsed or refractory multiple myeloma.
Timeline
- Start
- 2001-04
- Primary completion
- 2007-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AE-941 | Unknown | — | Oral |